Orthonairoviruses, a family of tick-borne pathogens, can bypass human immune defenses using specialized proteins called ovarian tumor domain proteases (OTUs), according to a study led by University of California, Riverside (UCR). This mechanism allows viruses like the Crimean-Congo hemorrhagic fever virus to suppress the body’s ability to detect and fight infection, increasing pandemic risk. How … Read more
New research from University College London (UCL) and Great Ormond Street Hospital (GOSH) indicates that effective respiratory syncytial virus (RSV) treatments for infants must target both the virus and the host’s immune response. Published in Nature Communications, the study utilized a novel lab-grown model of infant airways to demonstrate that the pediatric immune system triggers … Read more
Researchers from the Department of Breast Surgery at Fudan University Shanghai Cancer Center and the Department of Oncology at Shanghai Medical College, Fudan University have developed a new classification system for breast cancer based on the cancer-immunity cycle (CIC). Published in Cancer Biology & Medicine in 2026, this framework uses a “CIC score” to categorize … Read more
Researchers at the RCSI University of Medicine and Health Sciences have developed a novel mRNA vaccine for neuroblastoma using self-assembling peptide nanoparticles. According to study lead Olga Piskareva, the vaccine, which targets the glypican 2 (GPC2) antigen, reduced tumor volume by 70% in murine models. This approach offers a potential alternative to traditional lipid-based delivery … Read more
The End of “Reactive” Medicine: How AI is Ending the Pandemic Chase For decades, humanity has played a high-stakes game of cat-and-mouse with viruses. When a new pathogen emerges, scientists rush to sequence it, manufacture a targeted vaccine, and scramble to distribute it—often just as the virus begins to mutate into something new. We see … Read more
The Neuroimmune Frontier: Redefining How We Fight Lung Cancer For decades, the battle against lung cancer has focused primarily on two fronts: attacking the tumor directly and boosting the immune system to recognize and destroy malignant cells. However, a groundbreaking discovery from the Francis Crick Institute suggests we have been missing a critical piece of … Read more
The Evolution of Pediatric Immunization: Moving Beyond the Needle For many children, the annual flu shot is less about health and more about the fear of the needle. This psychological barrier, known as needle phobia, often leads to distress for both the child and the parent, sometimes resulting in delayed or skipped vaccinations. However, a … Read more
The Shift Toward Precision Inflammation Control For decades, the medical community has viewed inducible nitric oxide synthase (iNOS) primarily as a factory for nitric oxide. The prevailing assumption was that this protein drove inflammation through the chemicals it produced. However, groundbreaking research published in Nature Metabolism has revealed a hidden side to iNOS: it acts … Read more
Beyond the Infection: Understanding Placental Recovery For a long time, a critical question lingered for clinicians and expectant mothers: does the virus that causes COVID-19 stay hidden in the placenta long after a mother has recovered? Recent findings from Yale researchers, published in JAMA Network Open, provide a significant answer that shifts how we view … Read more
The Evolution of mRNA: From Pandemic Response to Cancer Treatment The global response to the COVID-19 pandemic accelerated a technological leap that is now reshaping oncology. MRNA technology, which provided the blueprint for vaccines like Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax, is moving beyond viral prevention to target some of the most challenging forms of cancer. … Read more